Ultrasonographic assessment of luteinized unruptured follicle syndrome in unexplained infertility.
Ultrasound can be used to monitor the growth and rupture of the dominant follicle. Thirty-three patients with unexplained infertility underwent serial sonography (mean, 3.2 scans/cycle) for luteinized unruptured follicle syndrome (LUFS). The incidence of LUFS was 9% (three patients) in the initial scan cycle. Three patients (9%) demonstrated rupture of a follicle significantly smaller than the mean (22.1 mm) (z less than 0.01) in the initial scan cycle. At standard radiology fees ($7000 +/ diagnosed LUFS) the cost/benefit ratio of this method of diagnosis will be controversial. It is suggested that scanning at reduced fees in the gynecologist's office, particularly in conjunction with postcoital tests, would decrease cost and increase the potential benefit.
D000553:Ambulatory Care / Q000191:economics; D001831:Body Temperature; D006063:Chorionic Gonadotropin / Q000627:therapeutic use; D002996:Clomiphene / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy / Q000503:physiopathology*; D008183:Luteal Phase; D006080:Ovarian Follicle / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology*; D010060:Ovulation; D014463:Ultrasonography / Q000191:economics
D006063:Chorionic Gonadotropin; D002996:Clomiphene